Literature DB >> 28374059

Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.

Vera S Schneider1, Carsten Skurk1, Matthias Riedel1, Youssef S Abdelwahed1, Ulf Landmesser1, David M Leistner2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28374059     DOI： 10.1007/s00392-017-1091-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  7 in total

1.  Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold.

Authors:  Daniel Braun; Moritz Baquet; Steffen Massberg; Julinda Mehilli; Jörg Hausleiter
Journal:  JACC Cardiovasc Interv       Date:  2015-12-09       Impact factor: 11.195

2.  A potential life-threatening complication after implantation of a bioresorbable scaffold for coronary stenting within a mechanically stressed region.

Authors:  Karin Schinke; Nicolas Langwieser; Karl-Ludwig Laugwitz; Tareq Ibrahim
Journal:  Clin Res Cardiol       Date:  2015-01-20       Impact factor: 5.460

3.  Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.

Authors:  Monique Tröbs; Stephan Achenbach; Jens Röther; Lutz Klinghammer; Christian Schlundt
Journal:  Catheter Cardiovasc Interv       Date:  2016-05-03       Impact factor: 2.692

4.  Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

Authors:  Patrick W Serruys; Bernard Chevalier; Yohei Sotomi; Angel Cequier; Didier Carrié; Jan J Piek; Ad J Van Boven; Marcello Dominici; Dariusz Dudek; Dougal McClean; Steffen Helqvist; Michael Haude; Sebastian Reith; Manuel de Sousa Almeida; Gianluca Campo; Andrés Iñiguez; Manel Sabaté; Stephan Windecker; Yoshinobu Onuma
Journal:  Lancet       Date:  2016-10-30       Impact factor: 79.321

5.  The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment.

Authors:  Robert J Gil; Jacek Bil; Tomasz Pawłowski; Nabijon Yuldashev; Leszek Kołakowski; Jacek Jańczak; Wojciech Jabłoński; Piotr Paliński
Journal:  Kardiol Pol       Date:  2016-01-18       Impact factor: 3.108

6.  Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.

Authors:  Lorenz Räber; Salvatore Brugaletta; Kyohei Yamaji; Crochan J O'Sullivan; Shuji Otsuki; Tobias Koppara; Masanori Taniwaki; Yoshinobu Onuma; Xavier Freixa; Franz R Eberli; Patrick W Serruys; Michael Joner; Manel Sabaté; Stephan Windecker
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

7.  Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios.

Authors:  Milosz Jaguszewski; Jelena-Rima Ghadri; Manuel Zipponi; Dana Roxana Bataiosu; Johanna Diekmann; Verena Geyer; Catharina Anna Neumann; Mia Aurelia Huber; Christian Hagl; Paul Erne; Thomas F Lüscher; Christian Templin
Journal:  Clin Res Cardiol       Date:  2014-08-31       Impact factor: 5.460
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.